BIOINFORMATICS SHARED RESOURCE (BISR) The Bioinformatics Shared Resource (BISR) continues to provide cutting-edge support in bioinformatics and computational biology for basic, translational, and clinical research programs throughout MD Anderson. Its personnel include 15 faculty, 15 statistical analysts, 2 bioanalysts, and 10 software engineers, all associated with the Department of Bioinformatics and Computational Biology (DBCB) led by John Weinstein, MD, PhD. DBCB, a leader in bioinformatics nationally and internationally, provides high-quality academic research, education, and computer science as vital ?infrastructure? for the BISR's support function. The BISR analyzes a comprehensive spectrum of bioinformatic data types, including sequences (whole genome, whole exome, RNA-seq, ChIP-seq, ChiRP-seq; bisulfite-seq, ATAC-seq, etc.); DNA, RNA, and protein microarrays; flow cytometry (fluorescence and CyTOF); mass spectrometry (targeted and discovery for proteomics and metabolomics); siRNA, shRNA; CRISPR/Cas9; histopathological and clinical images including CyTOF images; and marker-driven clinical trial data. In addition, BISR faculty and software engineering teams develop professional-grade, user-friendly visualization and analysis software for use at MD Anderson and worldwide. BISR faculty are currently lead principal investigators on 4 NIH U24 grants and an NIH U01 grant for development, application, and sharing of the software. The BISR is proactive in education, both for the next generation of informatics specialists (through the MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Rice University, and Baylor College of Medicine) and for biologists and clinical researchers who wish to learn elements of data science. Bioinformatics assistance can be requested through 1) the BISR website, 2) weekly walk-in clinics, 3) informal contact, or 4) a DBCB faculty member designated as a liaison for each department or program. As much as possible, BISR analysts and faculty work longitudinally with particular departments and programs to maximize continuity and domain expertise. Over the previous grant cycle, the BISR has supported >900 projects for 355 cancer center members (219 with peer-reviewed funding) in 64 MD Anderson departments, representing all 16 CCSG programs. Included were all 13 MD Anderson Moon Shots plus SPOREs, P01s, and R01s. The most active BISR users were the Head and Neck Cancer (21% total usage), Hematologic Malignancies (15%), and Lung Cancer (11%) CCSG programs. Peer-review funded investigators accounted for 85% of the usage, and 6% ($240,027) of total costs are requested from the CCSG. The BISR has no chargebacks, but users are expected to provide support if their projects are large. BISR faculty averaged 10.3 authorships in 2017, with more than 500 authorships over the 6-year period. BISR staff plus faculty have contributed to 865 papers since the last review: 114 (13%) in journals with IF >20, 273 (32%) in those with IF >10, and 624 (72%) in those with IF >5. The BISR's focus on issues of rigor, reproducibility, accessibility, and interoperability is in tune with FAIR principles and the NIH's new Data Science initiative, in which DBCB is primed to participate.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016672-43
Application #
9794666
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Ohri, Nisha; Sittig, Mark P; Tsai, Chiaojung Jillian et al. (2018) Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis. Cancer 124:482-490
Cao, Qizhen; Yan, Xinrui; Chen, Kai et al. (2018) Macrophages as a potential tumor-microenvironment target for noninvasive imaging of early response to anticancer therapy. Biomaterials 152:63-76
Vichaya, Elisabeth G; Dantzer, Robert (2018) Inflammation-induced motivational changes: Perspective gained by evaluating positive and negative valence systems. Curr Opin Behav Sci 22:90-95
Nguyen, Jennifer; Jiao, Jingjing; Smoot, Kristin et al. (2018) Toll-like receptor 4: a target for chemoprevention of hepatocellular carcinoma in obesity and steatohepatitis. Oncotarget 9:29495-29507
Reddy, S M; Barcenas, C H; Sinha, A K et al. (2018) Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity. Br J Cancer 118:17-23
Reyes-Gibby, Cielito C; Wang, Jian; Yeung, Sai-Ching J et al. (2018) Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep 8:8789
Roland, Christina L; Bednarski, Brian K; Watson, Kelsey et al. (2018) Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol 117:879-885
Gulhati, Pat; Raghav, Kanwal; Shroff, Rachna et al. (2018) Phase II Study of Panitumumab in RAS Wild-Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater. Oncologist 23:277-e26
Bhattacharya, Rajat; Ellis, Lee M (2018) It Is Time to Re-Evaluate the Peer Review Process for Preclinical Research. Bioessays 40:
Boddu, Prajwal; Oviedo, Sergio Pina; Rausch, Caitlin R et al. (2018) PET-CT in AML-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 59:1486-1489

Showing the most recent 10 out of 12418 publications